Abstract:The gut microbiome has emerged as an important factor affecting human health and disease. The recent development of –omics approaches, including phylogenetic marker-based microbiome profiling, shotgun metagenomics, metatranscriptomics, metaproteomics, and metabolomics, has enabled efficient characterization of microbial communities. These techniques can provide strain-level taxonomic resolution of the taxa present in microbiomes, assess the potential functions encoded by the microbial community and quantify the metabolic activities occurring within a complex microbiome. The application of these meta-omics approaches to clinical samples has identified microbial species, metabolic pathways, and metabolites that are associated with the development and treatment of human diseases. These findings have further facilitated microbiome-targeted drug discovery and efforts to improve human health management. Recent in vitro and in vivo investigations have uncovered the presence of extensive drug-microbiome interactions. These interactions have also been shown to be important contributors to the disparate patient responses to treatment that are often observed during disease therapy. Therefore, developing techniques or frameworks that enable rapid screening, detailed evaluation, and accurate prediction of drug/host-microbiome interactions is critically important in the modern era of microbiome research and precision medicine. Here we review the current status of meta-omics techniques, including integrative multi-omics approaches, for characterizing the microbiome's functionality in the context of health and disease. We also summarize and discuss new frameworks for applying meta-omics approaches and microbiome assays to study drug-microbiome interactions. Lastly, we discuss and exemplify strategies for implementing microbiome-based precision medicines using these meta-omics approaches and high throughput microbiome assays.

Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health

Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications

The Role of Gut Microbiota Associated Metabolites in Digestive Disorders

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Using Metabolomics to Analyse the Role of Gut Microbiota in Nutrition and Disease

Uncovering the Carboxylated Metabolome in Gut Microbiota-Host Co-metabolism: A Chemical Derivatization-Molecular Networking Approach

Advancing functional and translational microbiome research using meta-omics approaches

Application of Metagenomics in the Human Gut Microbiome

Combined application of metagenomics and metabonomics techniques in human gastrointestinal ecosystem

Small molecules in the big picture of gut microbiome-host cross-talk

Application of metagenomics in the human gut microbiome.

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications

A Comparative Evaluation of Tools to Predict Metabolite Profiles From Microbiome Sequencing Data

Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation

A metabolomics pipeline for the mechanistic interrogation of the gut microbiome

Gut microbiome-host interactions in health and disease

Strain-level Dissection of the Contribution of the Gut Microbiome to Human Metabolic Disease

Gut microbial metabolites as multi-kingdom intermediates